Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters

Japanese Journal of Cancer Research

Volumn 89, Issue 2, 1998, Pages 131-136

  Furukawa, Fumio ^a   Nishikawa, Akiyoshi ^a   Imazawa, Takayoshi ^a   Kasahara, Ken Ichiro ^a   Takahashi, Michihito ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

BOP; Hamster; Pancreatic carcinogenesis; Quinacrine

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; MEPACRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; FEMALE; HEPATOPANCREAS; HISTOPATHOLOGY; KIDNEY ADENOMA; KIDNEY CARCINOMA; LAMELLAR BODY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CARCINOMA; LUNG ADENOCARCINOMA; LUNG ADENOMA; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 0031938028     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00540.x     Document Type: Article

References (20)

1. Rollo, I. Miscellaneous drugs used in the treatment of protozoal infections. In "The Pharmacological Basis of Therapeutics," ed. A. G. Gilman, L. S. Goodman and A. Gilman, pp. 1070-1079 (1980). Macmillan, New York.
2. Lüllman, H., Lüllman-Rauch, R. and Wassermann, O. Lipidosis induced by amphophilic cationic drugs. Biochem. Pharmacol., 27, 1103-1108 (1978).
3. De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P. and Van Hoof, F. Lysosomatopic agents. Biochem. Pharmacol., 23, 2495-2531 (1974).
4. Shikata, T., Kanetaka, T., Endo, Y. and Nagashima, K. Drug-induced generalized phospholipidosis. Acta Pathol. Jpn., 22, 517-531 (1972).
5. Gibb, W., Isenberg, D. and Snait, M. I. Mepacrine-induced hepatitis. Ann. Rheum. Dis., 44, 86 (1985).
6. Padrón, A. G., Toranzo, E. G. D. and Castro, J. A. Late preventive effects of quinacrine on carbon tetrachloride induced liver necrosis. Arch. Toxicol., 67, 386-391 (1993).
7. Cook, T. M. and Goldman, C. K. Hycanthone and its congeners as bacterial mutagens. J. Bacteriol., 122, 549-556 (1975).
8. Imaida, K., Yoshida, J., Uneyama, C., Ogasawara, H., Imazawa, T. and Hayashi, Y. Dose-dependent enhancing effects of quinacrine on induction of preneoplastic glututhione S-transferase placental form positive liver cell foci in male F344 rats. Carcinogenesis, 12, 1911-1915 (1991).
9. Pour, P., Althoff, J., Krüger, F. W. and Mohr, U. A potent pancreatic carcinogen in Syrian golden hamsters: N-nitrosobis(2-oxopropyl)amine. J. Natl. Cancer Inst., 58, 1449-1453 (1977).
10. Pour, P. M., Salmasi, S. Z. and Runge, R. G. Selective induction of pancreatic ductular tumors by single doses of N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters. Cancer Lett., 4, 317-323 (1978).
11. Montesano, R., Saffiotti, U. and Shubik, P. The role of topical and systemic factors in experimental respiratory carcinogenesis. In "Inhalation Carcinogenesis," ed. M. G. Hanna, Jr., P. Nettesheim and J. R. Gilbert, AEC Symposium Series Vol. 18, pp. 353-371 (1970). Oak Ridge, Tennessee.
12. Eustis, S. L., Boorman, G. A., Harada, T. and Popp, J. A. Liver. In "Pathology of the Fischer Rat," ed. G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr. and W. F. Mackenzie, pp. 71-94 (1990). Academic Press, San Diego.
13. Furukawa, F., Nishikawa, A., Imaida, K., Mitsui, M., Enaini, T., Hayashi, Y. and Takahashi, M. Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis, 13, 2133-2135 (1992).
14. 2 in prostaglundin biosynthesis. Biochem. Pharmacol., 25, 285-291 (1976).
15. Markus, H. B. and Ball, E. G. Inhibition of lipolytic processes in rat adipose tissue by antimalarial drugs. Biochim. Biophys. Acta, 187, 486-491 (1969).
16. Yorio, T. and Bentley, P. J. Phospholipase A and the mechanism of action of aldosterone. Nature, 271, 79-81 (1978).
17. McCormick, D. L., Madigan, M. J. and Moon, R. C. Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res., 45, 1803-1808 (1985).
18. McCormick, D. L. and Moon, R. C. Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal anti-inflammatory agent. Br. J. Cancer, 48, 859-861 (1983).
19. Takahashi, M., Furukawa, F., Toyoda, K., Sato, H., Hasegawa, R., Imaida, K. and Hayashi, Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis, 11, 393-395 (1990).
20. McCormick, D. L. Anticarcinogenic activity of quinacrine in the rat mammary gland. Carcinogenesis, 9, 175-178 (1988).